770 Journal of Medicinal Chemistry, 2009, Vol. 52, No. 3
Ott et al.
(2) Ott, I.; Gust, R. Non Platinum Metal Complexes as Anti-Cancer Drugs.
Arch. Pharm. Chem. Life Sci. 2007, 340, 117–126.
(3) Bruijnincx, P. C. A.; Sadler, P. J. New Trends for Metal Complexes
with Anticancer Activity. Curr. Opin. Chem. Biol. 2008, 12, 197–
206.
(23) Rackham, O.; Nichols, S. J.; Leedman, P. J.; Berners-Price, S. J.;
Filipovska, A. A Gold(I) Phosphine Complex Selectively Induces
Apoptosis in Breast Cancer Cells: Implications for Anticancer
Therapeutics Targeted to Mitochondria. Biochem. Pharmacol. 2007,
74, 992–1002.
(24) Ott, I.; Scharwitz, M.; Scheffler, H.; Sheldrick, W. S.; Gust, R. Atomic
Absorption Spectrometric Determination of the Iridium Content in
Tumor Cells Exposed to an Iridium Metallodrug. J. Pharm. Biomed.
Anal. 2008, 47, 938–942.
(25) Kirin, S. I.; Ott, I.; Gust, R.; Mier, W.; Weyhermu¨ller, T.; Metzler-
Nolte, N. Cellular Uptake Quantification of Metalated Peptide and
Peptide Nucleic Acid Bioconjugates by Atomic Absorption Spectros-
copy. Angew. Chem., Int. Ed. 2008, 47, 955–958.
(26) Sergeant, C. D.; Ott, I.; Sniady, A.; Meneni, S.; Gust, R.; Rheingold,
A. L.; Dembinski, R. Metallo-nucleosides: Synthesis and Biological
Evaluation of Hexacarbonyldicobalt 5-Alkynyl-2′-deoxyuridines. Org.
Biomol. Chem. 2008, 6, 73–80.
(27) Marzano, C.; Gandin, V.; Folda, A.; Scutari, G.; Bindoli, A.; Rigobello,
M. P. Inhibition of Thioredoxin Reductase by Auranofin Induces
Apoptosis in Cisplatin-Resistant Human Ovarian Cancer Cells. Free
Radical Biol. Med. 2007, 42, 872–881.
(28) Rigobello, M. P.; Messori, L.; Marcon, G.; Cinellu, M. A.; Bragadin,
M.; Folda, A.; Scutari, G.; Bindoli, A. Mitochondrial Thioredoxin
Reductase Inhibition by Gold(I) Compounds and Concurrent Stimula-
tion of Permeability Transition and Release of Cytochrome C. J. Inorg.
Biochem 2004, 98, 1634–1641.
(29) Rush, G. F.; Smith, P. F.; Hoke, G. D.; Alberts, D. W.; Snyder, R. M.;
Mirabelli, C. K. The Mechanism of Acute Cytotoxicity of Trieth-
ylphosphine Gold(I) Complexes. II. Triethylphosphine Gold Chloride-
induced Alterations in Mitochondrial Function. Toxicol. Appl. Phar-
macol. 1987, 90, 391–400.
(30) Streicher, K. L.; Sylte, M. J.; Johnson, S. E.; Sordillo, L. M.
Thioredoxin Reductase Regulates Angiogenesis by Increasing Endot-
helial Cell-Derived Vascular Endothelial Growth Factor. Nutr. Cancer
2004, 50, 221–231.
(31) Powis, G.; Kirkpatrick, D. L. Thioredoxin Signaling as a Target For
Cancer Therapy. Curr. Opin. Pharmacol. 2007, 7, 392–397.
(32) Vacca, A.; Bruno, M.; Boccarelli, A.; Coluccia, M.; Ribatti, D.;
Bergamo, A.; Garbisa, S.; Sartor, L.; Sava, G. Inhibition of Endothelial
Cell Functions and of Angiogenesis by the Metastasis Inhibitor NAMI-
A. Br. J. Cancer 2002, 86, 993–998.
(33) Ott, I.; Kircher, B.; Bagowski, C. P.; Vlecken, D. H. W.; Ott, E. B.;
Will, J.; Bensdorf, K.; Sheldrick, W. S.; Gust, R. Modulation of the
Biological Properties of Aspirin by Bioorganometallic Derivatisation.
Angew. Chem., Int. Ed., DOI: 10.1002/ange.200803347.
(34) Norrby, K. In Vivo Models of Angiogenesis. J. Cell. Mol. Med. 2006,
10, 588–612.
(35) Habeck, H.; Odenthal, J.; Walderich, B.; Maischein, H.; Schulte-
Merker, S.; Tu¨bingen 2000 Screen Consortium. Analysis of a Zebrafish
VEGF Receptor Mutant Reveals Specific Disruption of Angiogenesis.
Curr. Biol. 2002, 12, 1404–1412.
(36) Isenberg, J. S.; Jia, Y.; Field, L.; Ridnour, L. A.; Sparatore, A.; Del
Soldato, P.; Sowers, A. L.; Yeh, G. C.; Moody, T. W.; Wink, D. A.;
Ramchandran, R.; Roberts, D. D. Modulation of Angiogenesis by
Dithiolethione Modified NSAIDs and Valproic Acid. Br. J. Pharmacol.
2007, 151, 142–151.
(37) Lawson, N. D.; Weinstein, B. M. In Vivo Imaging of Embryonic
Vascular Development Using Transgenic Zebrafish. DeV. Biol. 2002,
248, 307–318.
(38) Ott, I.; Schmidt, K.; Kircher, B.; Schumacher, P.; Wiglenda, T.; Gust,
R. Antitumor-Active Cobalt-Alkyne Complexes Derived from Ace-
tylsalicylic Acid: Studies on the Mode of Drug Action. J. Med. Chem.
2005, 48, 622–629.
(39) Nicoletti, I.; Migliorati, G.; Pagliacci, M. G.; Grignani, F.; Riccardi,
C. A Rapid and Simple Method for Measuring Thymocyte Apoptosis
by Propidium Iodide Staining and Flow Cytometry. J. Immunol.
Methods 1991, 139, 271–279.
(40) Riccardi, C.; Nicoletti, I. Analysis of Apoptosis by Propidium Iodide
Staining and Flow Cytometry. Nat. Protoc. 2006, 1, 1458–1461.
(41) Fadok, V. A.; Xue, D.; Henson, P. If Phosphatidylserine Is the Death
Knell, a New Phosphatidylserine-Specific Receptor Is the Bellringer.
Cell Death Differ. 2001, 8, 582–587.
(42) Schlegel, R. A.; Williamson, P. Phosphatidylserine, a Death Knell.
Cell Death Differ. 2001, 8, 551–563.
(4) Hambley, T. W. Metal-Based Therapeutics. Science 2007, 318, 1392–
1393.
(5) Gromer, S.; Arscott, L. D.; Williams, C. H.; Schirmer, R. H.; Becker,
K. Human Placenta Thioredoxin Reductase. Isolation of the Sele-
noenzyme, Steady State Kinetics, and Inhibition by Therapeutic Gold
Compounds. J. Biol. Chem. 1998, 273, 20096–200101.
(6) Barnard, P. J.; Berners-Price, S. J. Targeting the Mitochondrial Cell
Death Pathway with Gold Compounds. Coord. Chem. ReV. 2007, 251,
1889–1902.
(7) Urig, S.; Fritz-Wolf, K.; Reau, R.; Herold-Mende, C.; Toth, K.;
Davioud-Charvet, E.; Becker, K. Undressing of Phosphine Gold(I)
Complexes as Irreversible Inhibitors of Human Disulfide Reductases.
Angew. Chem., Int. Ed. 2006, 45, 1881–1886.
(8) Mirabelli, C. K.; Johnson, R. K.; Hill, D. T.; Faucette, L. F.; Girard,
G. R.; Kuo, G. Y.; Sung, C. M.; Crooke, S. T. Correlation of the in
Vitro Cytotoxic and in Vivo Antitumor Activities of Gold(I) Coordina-
tion Complexes. J. Med. Chem. 1986, 29, 218–223.
(9) Brana, M. F.; Ramos, A. Naphthalimides as Anti-Cancer Agents:
Synthesis and Biological Activity. Curr. Med. Chem.: Anti-Cancer
Agents 2001, 1, 237–255.
(10) Ott, I.; Xu, Y.; Liu, J.; Kokoschka, M.; Harlos, M.; Sheldrick, W. S.;
Qian, X. Sulfur-Substituted Naphthalimides as Photoactivatable
Anticancer Agents: DNA Interaction, Fluorescence Imaging, and
Phototoxic Effects in Cultured Tumor Cells. Bioorg. Med. Chem. 2008,
16, 7107–7116.
(11) Cao, H.; Chang, V.; Hernandez, R.; Hagy, M. D. Matrix Screening of
Substituted N-Aryl-1,8-naphthalimides Reveals New Dual Fluorescent
Dyes and Unusually Bright Pyridine Derivatives. J. Org. Chem. 2005,
70, 4929–4934.
(12) Pardo, A.; Poyato, J. M. L.; Martin, E. Photophysical Properties of
1,8-Naphthalimide Derivatives. J. Photochem. 1987, 36, 323–329.
(13) Ramachandram, B.; Saroja, G.; Sankaran, N. B.; Samanta, A.
Unusually High Fluorescence Enhancement of Some 1,8-Naphthal-
imide Derivatives Induced by Transition Metal Salts. J. Phys. Chem.
B 2000, 104, 11824–11832.
(14) Zhang, Z.; Wu, D.; Guo, X.; Qian, X.; Lu, Z.; Xu, Q.; Yang, Y.;
Duan, L.; He, Y.; Feng, Z. Visible Study of Mercuric Ion and Its
Conjugate in Living Cells of Mammals and Plants. Chem. Res. Toxicol.
2005, 18, 1814–1820.
(15) Gan, J.; Tian, H.; Wang, Z.; Chen, K.; Hill, J.; Lane, P. A.; Rahn,
M. D.; Fox, A. M.; Bradley, D. D. C. Synthesis and Luminescence
Properties of Novel Ferrocene-Naphthalimides Dyads. J. Organomet.
Chem. 2002, 645, 168–175.
(16) Guo, X.; Qian, X.; Jia, L. A Highly Selective and Sensitive Fluorescent
Chemosensor for Hg2+ in Neutral Buffer Aqueous Solution. J. Am.
Chem. Soc. 2004, 126, 2272–2273.
(17) Xu, Z.; Qian, X.; Cui, J. Colorimetric and Ratiometric Fluorescent
Chemosensor with a Large Red-Shift in Emission: Cu(II)-Only Sensing
by Deprotonation of Secondary Amines as Receptor Conjugated to
Naphthalimide Fluorophore. Org. Lett. 2005, 7, 3029–3032.
(18) Osawa, M.; Hoshino, M.; Hashizume, D. Photoluminescent Properties
and Molecular Structures of [NaphAu(PPh3)] and [µ-Naph
{Au(PPh3)}2]ClO4 (Naph ) 2-naphthyl). Dalton Trans. 2008, 2248–
2252.
(19) Ott, I.; Scheffler, H.; Gust, R. Development of a Method for the
Quantification of the Molar Gold Concentration in Tumour Cells
Exposed to Gold-Containing Drugs. ChemMedChem 2007, 2, 702–
707.
(20) Ott, I.; Koch, T.; Shorafa, H.; Bai, Z.; Poeckel, D.; Steinhilber, D.;
Gust, R. Synthesis, Cytotoxicity, Cellular Uptake and Influence on
Eicosanoid Metabolism of Cobalt-Alkyne Modified Fructoses in
Comparison to Auranofin and the Cytotoxic COX Inhibitor Co-ASS.
Org. Biomol. Chem. 2005, 3, 2282–2286.
(21) Barnard, P. J.; Wedlock, L. E.; Baker, M. V.; Berners-Price, S. J.;
Joyce, D. A.; Skelton, B. W.; Steer, J. H. Luminescence Studies of
the Intracellular Distribution of a Dinuclear Gold(I) N-Heterocyclic
Carbene. Angew. Chem. 2006, 118, 6112–6116.
(22) Liu, J. J.; Galettis, P.; Farr, A.; Maharaj, L.; Samarasinha, H.;
McGechan, A. C.; Baguley, B. C.; Bowen, R. J.; Berners-Price, S. J.;
McKeage, M. J. In Vitro Antitumour and Hepatotoxicity Profiles of
Au(I) and Ag(I) Bidentate Pyridyl Phosphine Complexes and Relation-
ships to Cellular Uptake. J. Inorg. Biochem. 2008, 102, 303–310.
(43) Vermes, I.; Haanen, C.; Steffens-Nakken, H.; Reutellingsperger, C.
A Novel Assay for Apoptosis. J. Immunol. Methods 1995, 184, 39–51.
JM8012135